HomeCompareCHEK vs EQR

CHEK vs EQR: Dividend Comparison 2026

CHEK yields 119.05% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHEK wins by $8.20M in total portfolio value
10 years
CHEK
CHEK
● Live price
119.05%
Share price
$1.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.24M
Annual income
$3,108,090.72
Full CHEK calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — CHEK vs EQR

📍 CHEK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHEKEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHEK + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHEK pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHEK
Annual income on $10K today (after 15% tax)
$10,119.05/yr
After 10yr DRIP, annual income (after tax)
$2,641,877.11/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, CHEK beats the other by $2,638,630.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHEK + EQR for your $10,000?

CHEK: 50%EQR: 50%
100% EQR50/50100% CHEK
Portfolio after 10yr
$4.14M
Annual income
$1,555,955.16/yr
Blended yield
37.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CHEK
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Altman Z
-715.9
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHEK buys
0
EQR buys
0
No recent congressional trades found for CHEK or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHEKEQR
Forward yield119.05%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$8.24M$40.5K
Annual income after 10y$3,108,090.72$3,819.61
Total dividends collected$7.49M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: CHEK vs EQR ($10,000, DRIP)

YearCHEK PortfolioCHEK Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$22,605$11,904.76$11,248$547.57+$11.4KCHEK
2$49,337$25,149.94$12,701$666.53+$36.6KCHEK
3$104,092$51,301.04$14,405$814.59+$89.7KCHEK
4$212,533$101,154.53$16,413$999.84+$196.1KCHEK
5$420,434$193,023.94$18,795$1,232.92+$401.6KCHEK
6$806,726$356,861.32$21,639$1,527.95+$785.1KCHEK
7$1,503,143$639,946.75$25,057$1,903.80+$1.48MCHEK
8$2,722,746$1,114,383.27$29,197$2,385.87+$2.69MCHEK
9$4,799,842$1,886,503.76$34,250$3,008.70+$4.77MCHEK
10$8,243,922$3,108,090.72$40,467$3,819.61+$8.20MCHEK

CHEK vs EQR: Complete Analysis 2026

CHEKStock

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Full CHEK Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CHEK vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHEK vs SCHDCHEK vs JEPICHEK vs OCHEK vs KOCHEK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.